Neviar, Daisy P.
HRN: 26-48-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2025
CEFUROXIME 500MG (TAB)
02/13/2025
02/19/2025
ORAL
500mg
2 Times A Day
S/P NSVD
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes